Abstract
Research in the field of medical treatment is based on the assessment of variables that are aimed at by the therapy under question. Even if it is tempting and easy to choose a single laboratory parameter for measurement, it is the improvement of the patient’s general clinical status that is of utmost importance before introducing a new therapy. The assessment of a stroke patient seems to be particularly difficult, as a stroke commonly leads to a variety of more or less independent signs that may or may not be improved by a drug in different ways. Is the treatment of benefit to the patient or not if his or her moderate paresis completely resolves but at the same time Broca’s aphasia deteriorates to global aphasia? In the following we will try to analyze how different stroke scales have dealt with this problem. We will focus on scales that attempt to quantify deficit or residual abilities once stroke has occurred. We will not touch on the methodological problems that one has to face in a stroke prevention trial when an ischemic event or death occurs in a previously healthy or at-risk patient.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adams RJ, Meador KJ, Sethi KD, Grotta JC, Thompson DS (1987) Graded neurological scale for use in acute hemispheric stroke treatment protocols. Stroke 18:665–669
Brott T, Adams HP, Olinger CP, et al (1989) Measurements of acute cerebral infarction: A clinical examination scale. Stroke 20:864–870
Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Measur 20:34–46
Cote R, Battista RN, Wolfson C, Boucher J, Adams J, Hachinski VC (1989) The Canadian Neurological Scale: Validation and reliability assessment. Neurology 39:638–643
Cote R, Hachinski VC, Shurtell BL, Norris JW, Wolfson C (1986) The Canadian Neurological Scale: A preliminary study in acute stroke. Stroke 17:731–737
European Carotid Surgery Trialist’s Collaborative Group (1991) MRC European carotid surgery trial: Interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 337:1235–1243
Fugl-Meyer AR, Jääskö L, Leyman I, Olsson S, Steglind S (1975) I. A method for evaluation of physical performance. Scand J Rehabil Med 7:13–31
Gelmers HJ, Gorter K, de Weerdt CJ, Wiezer HJA (1988) Assessment of interobserver variability in a Dutch multicenter study on acute ischemic stroke. Stroke 19:709–711
Gelmers HJ, Hennerici M (1990) Effect of nimodipine on acute ischemic stroke pooled results from five randomized trials. Stroke 21(Suppl IV):IV-81–IV-84
Goldstein LB, Bertels C, Davis JN (1989) Interrater reliability of the NIH Stroke Scale. Arch Neurol 46:660–662
Koziol JA, Hacke W (1990) Multivariate data reduction by principal components, with application to neurological scoring instruments. J Neurol 237:461–464
Krauth J (1984) A modification of kappa for intraobserver bias. Biom J 26:435–445
Loewen SC, Anderson BA (1988) Reliability of the modified motor assessment scale and the Barthel index. Phys Ther 68:1077–1081
Mahoney FJ, Barthel DW (1965) Functional evaluation. The Barthel index. Md Med J 14:61–65
Mathew NT, Rivera VM, Meyer JS, Charney JZ, Hartmann A (1972) Double-blind evaluation of glycerol therapy in acute cerebral infarction. Lancet December 23:7791–7793
Rankin J (1957) Cerebral vascular accident in patients over the age of 60. II. Prognosis. Scott Med J 2:200–215
Scandinavian Stroke Study Group (1985) Multicenter trial of hemodilution in ischemic stroke — background and study protocol. Stroke 16:885–890
Shinar D, Gross CR, Mohr JP, et al (1985) Interobserver variability in the assessment of neurologic history and examination in the Stroke Data Bank. Arch Neurol 42:557–565
Sisk C, Ziegler DK, Zileli T (1970) Discrepancies in recorded results from duplicate neurological history and examination in patients studied for prognosis in cerebrovascular disease. Stroke 1:14–18
Skyhoj-Olsen T (1990) Arm and leg paresis as outcome predictors in stroke rehabilitation. Stroke 21:247–251
The Dutch TIA Study Group. (1988) The Dutch TIA Trial: Protective effects of low-dose aspirin and atenolol in patients with transient ischemic attacks or nondisability stroke. Stroke 19:512–517
UK TPA Study Group (1988) The UK-TPA aspurin trial. Interim results. Br Med J 296:316–320
van Gijn J (1992) Measurement of outcome in stroke prevention trials. Cerebrovasc Dis 2(Suppl 1):23–34
van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604–607
Wade DT, Hewer RL (1987) Functional abilities after stroke: Measurement, natural history and prognosis. J Neurol Neurosurg Psychiatry 50:177–182
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Ferbert, A., Willmes, K. (1993). The Relevance of Neurological and Functional Outcome Scales for Acute Stroke Trials. In: del Zoppo, G.J., Mori, E., Hacke, W. (eds) Thrombolytic Therapy in Acute Ischemic Stroke II. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78061-5_31
Download citation
DOI: https://doi.org/10.1007/978-3-642-78061-5_31
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56442-3
Online ISBN: 978-3-642-78061-5
eBook Packages: Springer Book Archive